IntelliSite Pathology supports remote collaboration and teamwork, aiding diagnosis, boosting productivity, addressing staff shortages and cutting costs. The comprehensive, scalable system integrates hardware, software, storage, analysis and enterprise-wide connectivity. It provides pathologists with fully integrated, end-to-end workflows to deliver accurate diagnoses and improve patient outcomes.
Earlier this year, Philips struck a deal with Amazon Web Services (AWS) to advance digital pathology with IntelliSite. This itengration enables third-party, AI-driven diagnostic applications.
IntelliSite Pathology helps shorten the time needed to review, report and sign off on cases while also allowing pathologists to work remotely. Philips says that enabling remote collaboration and leveraging cloud-based AI, clinicians can deliver timely precision diagnoses. By securely lifting data out of the pathology lab, care teams can access it at every stage of the patient journey, too.
Philips’ open-platform approach to data also facilitates medical research and could enable the development of new diagnostic algorithms. The company says it could also help develop disease biomarkers and treatment options.
“Digital pathology is helping to revolutionize how we diagnose and potentially treat cancer. With the 510(k) approval we expand our ability to help pathology laboratories transform to fully digital workflows, saving time and easing the burden on pathologists and patients,” said Martijn Hartjes, clinical informatics business leader at Philips. “We are advancing the digital transformation in pathology and multi-disciplinary clinical collaboration between pathologists, radiologists, oncologists, and other healthcare professionals, empowering clinicians with the tools they need to deliver improved patient outcomes and care.”
